F-star
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.
Business Model:
Revenue: $21.9M
Employees: 51-200
Industries / Tags:
Detailed F-star Information
F-star was acquired by
invoX Pharma.
The acquisition happend on 2022-06-23.
Details of the transaction were not public
Acquirer
Geographic Data
Address: Eddeva B920
City: Cambridge
State: england
Zip: CB22 3AT
Country: GB
Financial Info
Stage:
post ipo equity
Raised Last:
$65M
Raised Total:$55M
Social
Metrics
1,876,753Website Global Rank
11,684Website Monthly Traffic
Twitter Followers
Description
F-star is an England-based biotechnology company that develops and commercializes novel antibody therapies for the treatment of cancer and orphan diseases.
Contact Phone:
Contact Email:
F-star went public on 5/1/2016 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/1/2016
Ticker Symbol:
FSTX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2020 | Spring Bank Pharmaceuticals |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
